Literature DB >> 10722572

Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani.

S E Cotterell1, C R Engwerda, P M Kaye.   

Abstract

In this study, we have analyzed hematopoietic activity in the spleen, bone marrow, and blood of BALB/c and scid mice infected with Leishmania donovani. Our analysis demonstrates that infection induces a rapid but transient mobilization of progenitor cells into the circulation, associated with elevated levels of granulocyte/macrophage colony-stimulating factor (GM-CSF) and MIP-1alpha. From 14 to 28 days postinfection, when parasite expansion begins in the spleen and bone marrow, both the frequency and cell cycle activity of hematopoietic progenitors, particulary CFU-granulocyte, monocyte, are dramatically increased in these organs. This is associated with increased accumulation of mRNA for GM-CSF, M-CSF, and G-CSF, but not interleukin-3. Our data also illustrate that hematopoietic activity, as assessed by changes in the frequency of progenitor cell populations and their levels of cell cycle activity, can be regulated in both a T-cell-independent and T-cell-dependent, as well as in an organ-specific, manner. Collectively, these data add to our knowledge of the long-term changes which occur in organs in which L. donovani is able to persist.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722572      PMCID: PMC97356          DOI: 10.1128/IAI.68.4.1840-1848.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Control of hemopoiesis in mice by sensitized L3T4+ Lyt2-lymphocytes during infection with bacillus Calmette-Guérin.

Authors:  G Marchal; G Milon
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

2.  Increased myelopoiesis during Leishmania major infection in mice: generation of 'safe targets', a possible way to evade the effector immune mechanism.

Authors:  A M Mirkovich; A Galelli; A C Allison; F Z Modabber
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

3.  Differences in Lsh gene control over systemic Leishmania major and Leishmania donovani or Leishmania mexicana mexicana infections are caused by differential targeting to infiltrating and resident liver macrophage populations.

Authors:  E V Davies; A M Singleton; J M Blackwell
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

4.  BCG-induced anaemia in mice: no direct effect of the growth of bacilli.

Authors:  G Milon; M Gheorghiu; M Lagranderie; M Lebastard; G Marchal
Journal:  Ann Immunol (Paris)       Date:  1984 Mar-Apr

5.  Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease.

Authors:  K Dorshkind; G M Keller; R A Phillips; R G Miller; G C Bosma; M O'Toole; M J Bosma
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

6.  An H-11-linked gene has a parallel effect on Leishmania major and L. donovani infections in mice.

Authors:  J M Blackwell; C Hale; M B Roberts; O M Ulczak; F Y Liew; J G Howard
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

7.  Colony-forming cells and colony-stimulating activity during listeriosis in genetically resistant or susceptible mice.

Authors:  A M Young; C Cheers
Journal:  Cell Immunol       Date:  1986-02       Impact factor: 4.868

8.  Susceptibility to murine cutaneous leishmaniasis correlates with the capacity to generate interleukin 3 in response to leishmania antigen in vitro.

Authors:  R Lelchuk; R Graveley; F Y Liew
Journal:  Cell Immunol       Date:  1988-01       Impact factor: 4.868

9.  Aggravation of experimental cutaneous leishmaniasis in mice by administration of interleukin 3.

Authors:  Z Y Feng; J Louis; V Kindler; T Pedrazzini; J F Eliason; R Behin; P Vassalli
Journal:  Eur J Immunol       Date:  1988-08       Impact factor: 5.532

10.  Isolation and characterization of resident stromal macrophages and hematopoietic cell clusters from mouse bone marrow.

Authors:  P R Crocker; S Gordon
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Clinical and experimental advances in treatment of visceral leishmaniasis.

Authors:  H W Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Association between Insulin-Like Growth Factor-I Levels and the Disease Progression and Anemia in Visceral Leishmaniasis.

Authors:  Flaviane Alves de Pinho; Célia Maria Vieira Vendrame; Bruna Leal Lima Maciel; Lucilene Dos Santos Silva; Samantha Ive Miyashiro; Selma Maria Bezerra Jerônimo; Hiro Goto
Journal:  Am J Trop Med Hyg       Date:  2019-04       Impact factor: 2.345

Review 3.  Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.

Authors:  Lynn Soong; Calvin A Henard; Peter C Melby
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

4.  A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection.

Authors:  Christian R Engwerda; Manabu Ato; Sara E J Cotterell; Tracey L Mynott; Asiya Tschannerl; Patricia M A Gorak-Stolinska; Paul M Kaye
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

5.  Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis.

Authors:  Anthony D Duong; Sadhana Sharma; Kevin J Peine; Gaurav Gupta; Abhay R Satoskar; Eric M Bachelder; Barbra E Wyslouzil; Kristy M Ainslie
Journal:  Mol Pharm       Date:  2013-02-12       Impact factor: 4.939

6.  Diminished hematopoietic activity associated with alterations in innate and adaptive immunity in a mouse model of human monocytic ehrlichiosis.

Authors:  Katherine C MacNamara; Rachael Racine; Madhumouli Chatterjee; Dori Borjesson; Gary M Winslow
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

7.  Influence of clinical status and parasite load on erythropoiesis and leucopoiesis in dogs naturally infected with leishmania (Leishmania) chagasi.

Authors:  Raquel Trópia de Abreu; Maria das Graças Carvalho; Cláudia Martins Carneiro; Rodolfo Cordeiro Giunchetti; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho; Wendel Coura-Vital; Rodrigo Corrêa-Oliveira; Alexandre Barbosa Reis
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

8.  Resistance to visceral leishmaniasis is severely compromised in mice deficient of bradykinin B2-receptors.

Authors:  Dirlei Nico; Daniel Ferreira Feijó; Naiara Maran; Alexandre Morrot; Julio Scharfstein; Marcos Palatnik; Clarisa Beatriz Palatnik-de-Sousa
Journal:  Parasit Vectors       Date:  2012-11-14       Impact factor: 3.876

9.  Leishmania donovani infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleen.

Authors:  William P Lafuse; Ryan Story; Jocelyn Mahylis; Gaurav Gupta; Sanjay Varikuti; Heidi Steinkamp; Steve Oghumu; Abhay R Satoskar
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

10.  Surveillance on the status of immune cells after Echinnococcus granulosus protoscoleces infection in Balb/c mice.

Authors:  Wei Pan; He-Jun Zhou; Yu-Juan Shen; Ying Wang; Yu-Xin Xu; Yuan Hu; Yan-Yan Jiang; Zhong-Ying Yuan; Chidiebere E Ugwu; Jian-Ping Cao
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.